Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancer Survival Analysis01:21

Cancer Survival Analysis

617
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
617
Longitudinal Research02:20

Longitudinal Research

13.0K
Sometimes we want to see how people change over time, as in studies of human development and lifespan. When we test the same group of individuals repeatedly over an extended period of time, we are conducting longitudinal research. Longitudinal research is a research design in which data-gathering is administered repeatedly over an extended period of time. For example, we may survey a group of individuals about their dietary habits at age 20, retest them a decade later at age 30, and then again...
13.0K
Assumptions of Survival Analysis01:15

Assumptions of Survival Analysis

361
Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
361
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

3.6K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.6K
Kidney Transplant III: Nursing Management01:16

Kidney Transplant III: Nursing Management

278
Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...
278
Preventive Healthcare Services01:30

Preventive Healthcare Services

1.8K
Preventive healthcare services keep people healthy via frequent check-ups, screening, and counseling. They primarily aid in disease prevention rather than treating an acute or chronic illness. Preventive treatment also keeps individuals productive and energetic, allowing them to work well into their retirement years. Examples of preventive care services include:
1.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A convolutional neural network for fully automated total metabolic tumor volume delineation in patients with aggressive Non-Hodgkin lymphoma.

European journal of nuclear medicine and molecular imaging·2026
Same author

Segmentation method comparison for baseline [<sup>18</sup>F]FDG PET-CT in follicular lymphoma patients.

EJNMMI physics·2026
Same author

Improving the predictive value of end-of-treatment PET/ CT in diffuse large B-cell lymphoma.

Haematologica·2026
Same author

Azacitidine to treat measurable residual disease in patients with MDS/AML: final long-term results of the RELAZA2 trial.

Blood·2025
Same author

Predicting 2-year time to progression in diffuse large B cell lymphoma using 3D CNNs on whole-body PET/CT scans.

EJNMMI research·2025
Same author

Clinical Practice Guideline: Colorectal Cancer—Diagnosis, Treatment, Prevention, and Long-Term Follow-Up Care.

Deutsches Arzteblatt international·2025
Same journal

The Prevalence of Hospitalized Cases of Necrotizing Fasciitis: Anatomical Distribution, Amputations, and In-Hospital Mortality, 2019-2024.

Deutsches Arzteblatt international·2026
Same journal

Subclinical Atrial Fibrillation: Detection, Stroke Risk, and Treatment.

Deutsches Arzteblatt international·2026
Same journal

Fewer Premature Births After Assisted Reproduction.

Deutsches Arzteblatt international·2026
Same journal

Femoral Artery Pseudoaneurysm Due to Stent Fracture in PAOD.

Deutsches Arzteblatt international·2026
Same journal

Pain-Adapted Full Weight-bearing After Ankle Fracture Surgery: A Multicenter, Pragmatic, Single-armed Prospective Study.

Deutsches Arzteblatt international·2026
Same journal

Popliteal Artery Entrapment Syndrome.

Deutsches Arzteblatt international·2026
See all related articles

Related Experiment Video

Updated: Jan 5, 2026

A New Technique for Treating Low-risk Prostate Cancer&#8212;Super Active Surveillance
05:19

A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance

Published on: November 7, 2025

608

Evidence-Based Follow-up for Adults With Cancer.

Ulrich Dührsen1, Karl-Matthias Deppermann, Christian Pox

  • 1Department of Haematology, University Hospital Essen; Department of Pneumology, Sana Kliniken Düsseldorf; Medical Clinic, Krankenhaus St. Josef-Stift Bremen; Medical Clinic 1, Klinikum Landshut.

Deutsches Arzteblatt International
|October 30, 2019
PubMed
Summary
This summary is machine-generated.

Follow-up care for cancer patients aims to detect recurrences and complications. Evidence for current follow-up care recommendations for colorectal cancer, lung cancer, and lymphoma is weak, necessitating adherence to existing guidelines.

More Related Videos

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

610

Related Experiment Videos

Last Updated: Jan 5, 2026

A New Technique for Treating Low-risk Prostate Cancer&#8212;Super Active Surveillance
05:19

A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance

Published on: November 7, 2025

608
Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

610

Area of Science:

  • Oncology
  • Cancer Survivorship
  • Evidence-Based Medicine

Background:

  • Follow-up care for cancer survivors is crucial for psychosocial support and early detection of health issues.
  • The underlying assumption is that early identification of cancer recurrence and treatment complications benefits patients.
  • This review focuses on evidence for follow-up care in colorectal cancer, lung cancer, and lymphoma.

Purpose of the Study:

  • To review the scientific evidence supporting current follow-up care recommendations for patients with colorectal cancer, lung cancer, and lymphoma.
  • To assess the efficacy of established follow-up care modalities in cancer survivorship.

Main Methods:

  • A selective literature search of PubMed was conducted.
  • The search was supplemented by the authors' clinical experience and guideline development expertise.

Main Results:

  • Follow-up intervals are typically shorter initially (3-6 months) and lengthen over time (6-12 months).
  • For colorectal cancer, colonoscopy is key; intensive follow-up showed a non-significant survival increase but more surgeries for recurrence without improving average survival.
  • CT scanning after lung cancer resection improves survival, while optimal follow-up for lymphoma remains unclear due to secondary illness risks.

Conclusions:

  • The scientific evidence supporting current follow-up care practices for cancer patients is limited.
  • Adherence to existing guidelines is recommended until more robust clinical data becomes available.